Menu

Chair of Chemical Safety Board to Step Down

Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.

May 25, 2018
Ashley Yeager

ISTOCK, DSZCVanessa Allen Sutherland will resign next month as chair of the US Chemical Safety & Hazard Investigation Board. With the vacancy, the board will drop to having only three members—two short of the standard five, C&EN reported earlier this week (May 22).

“The remaining board members will be required to vote on an interim executive, unless and until the White House nominates and the Senate confirms a new Chairperson,” the board, usually referred to as the Chemical Safety Board (CSB), says in a statement. However, that nomination is in doubt, C&EN notes, as the Trump administration has twice tried to shut down the CSB altogether.

Sutherland did not give a reason for stepping down. “I am saddened to leave the wonderful mission and incredible work of the CSB. This mission is unique and critically important because we are the only agency conducting independent, comprehensive root cause chemical incident investigations,” she says in the statement.

Before Sutherland signed on in 2015, CSB had a shaky history. Congress and President Barack Obama ousted former chair Rafael Moure-Eraso after evidence emerged suggesting he mismanaged the board. When Sutherland stepped in, she reprioritized investigations, focusing on the oldest ones and working forward. The organization, which appeared more stable with Sutherland’s leadership, now has 10 unresolved investigations, the oldest dating to 2014, C&EN reports.

With a three-member board, the greatest challenge “will be dividing up the responsibilities and being extraordinarily transparent,” former board member Gerald Poje, who served when CSB had only two members, tells C&EN. “They must engender the confidence of those with the power of the purse in Congress.”

However, CSB faces another struggle—encouraging investigators to stay. Numbers have dropped from 20 to 10, with five vacancies coming in the last six months, according to C&EN.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.